JP6521449B2 - Method of manufacturing chemical container with stopper - Google Patents

Method of manufacturing chemical container with stopper Download PDF

Info

Publication number
JP6521449B2
JP6521449B2 JP2015165849A JP2015165849A JP6521449B2 JP 6521449 B2 JP6521449 B2 JP 6521449B2 JP 2015165849 A JP2015165849 A JP 2015165849A JP 2015165849 A JP2015165849 A JP 2015165849A JP 6521449 B2 JP6521449 B2 JP 6521449B2
Authority
JP
Japan
Prior art keywords
container
solution container
drug solution
resin
stopper
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2015165849A
Other languages
Japanese (ja)
Other versions
JP2017042964A (en
Inventor
伸生 川村
伸生 川村
重剛 名定
重剛 名定
謙一郎 荒木
謙一郎 荒木
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nihon Yamamura Glass Co Ltd
Original Assignee
Nihon Yamamura Glass Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nihon Yamamura Glass Co Ltd filed Critical Nihon Yamamura Glass Co Ltd
Priority to JP2015165849A priority Critical patent/JP6521449B2/en
Publication of JP2017042964A publication Critical patent/JP2017042964A/en
Application granted granted Critical
Publication of JP6521449B2 publication Critical patent/JP6521449B2/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Description

本発明は、薬液が収容される栓体付き薬液容器の製造方法に関し、特に薬液の漏れを効果的に防ぐことのできる栓体付き薬液容器の製造方法に関する。   The present invention relates to a method of manufacturing a stopper-equipped chemical container in which a chemical solution is stored, and more particularly to a method of manufacturing a stopper-equipped chemical container capable of effectively preventing leakage of the chemical solution.

使い切りタイプの薬剤を収容するための薬液容器には、注射器などで薬液を抽出する口部が形成されており、この口部に別体のゴム製の栓体が設けられている。口部に設けられた栓体に注射器の針を刺して内部の薬液を吸い出す際、栓体と口部との密封状態が十分でない場合、薬液の漏れが生じるおそれがある。   The mouth part which extracts a medical fluid with a syringe etc. is formed in the medical fluid container for storing a single-use type medicine, and a separate rubber stopper is provided in this mouth. When the liquid medicine inside is sucked by inserting the needle of the syringe into the plug provided at the mouth, if the sealed state between the plug and the mouth is not sufficient, there is a possibility that the liquid medicine may leak.

特許文献1には、1次成形で軟質材を射出し、2次成形で軟質材に積層する形で硬質材を成形する成形方法が記載されている。特許文献2には、第1の金型で一方の成形体を成形し、第2の金型で他方の成形体を成形した後、両金型をスライドして合わせ、接合部分に樹脂を注入して、両成形体を一体化する製造方法が記載されている。   Patent Document 1 describes a molding method in which a hard material is molded in such a manner that a soft material is injected in primary molding and laminated on the soft material in secondary molding. In Patent Document 2, one molded body is molded with a first mold and the other molded body is molded with a second mold, and then both molds are slid and combined, and a resin is injected into the joint portion A manufacturing method is described in which both moldings are integrated.

特許文献3では、1次成形で得た第1次成形品に2次成形で樹脂を射出成形し、第1次成形品の接触部分を融解させ且つ第1成形品の全体を軟化させて、第1成形品に2次成形の樹脂を一体化している。特許文献4には、1次射出工程で1次成形品を成形し、この1次成形品のシール部に、2次射出工程で樹脂を射出して一体化する成形方法が記載されている。   In Patent Document 3, a resin is injection-molded on a primary molded product obtained by primary molding in secondary molding, the contact portion of the primary molded product is melted, and the entire first molded product is softened. The second molded resin is integrated with the first molded product. Patent Document 4 describes a molding method in which a primary molded product is molded in a primary injection process, and a resin is injected and integrated in a secondary injection process to a seal portion of the primary molded product.

特開2000−52377号公報Unexamined-Japanese-Patent No. 2000-52377 特開2001−278320号公報JP 2001-278320 A 特開2005−178097号公報JP 2005-178097 A 特開2009−61739号公報JP, 2009-61739, A

上記各特許文献の成形方法では、1次成形で得た成形品に、2次成形である射出成形によって成形した樹脂を密着させている。例えば1次成形としてブロー成形で薬液容器を成形し、この薬液容器の口部に、射出成形によって樹脂製栓体を密着させることが考えられる。しかし射出成形によって、樹脂製栓体を口部に単に固着させるだけでは密着力が十分ではなく、液漏れを生じさせるおそれがある。また内容物である薬液を絞り出す操作を行った場合には、高い内圧によって栓体にかかる力は大きくなり、液漏れが生じやすくなる。   In the molding method of each of the above patent documents, a resin molded by injection molding, which is secondary molding, is adhered to a molded product obtained by primary molding. For example, it is conceivable to form a drug solution container by blow molding as primary molding, and to closely attach a resin stopper to the mouth of the drug solution container by injection molding. However, simply adhering the resin plug to the mouth by injection molding does not have sufficient adhesion, and there is a risk of causing liquid leakage. In addition, when an operation of squeezing out the drug solution which is the contents is performed, the force applied to the plug increases due to the high internal pressure, and liquid leakage is likely to occur.

そこで本発明は従来技術の問題点に鑑み、液漏れを確実に防ぐことができる栓体付き薬液容器の製造方法を提供することを目的とする。   Therefore, in view of the problems of the prior art, an object of the present invention is to provide a method of manufacturing a stoppered chemical container capable of reliably preventing liquid leakage.

本発明の栓体付き薬液容器の製造方法は、薬液を抽出する口部を有すると共にこの口部を閉塞する閉塞膜が形成された熱可塑性樹脂製の薬液容器を形成する第1成形工程と、樹脂製栓体を成形するキャビティを備える成形金型に、前記閉塞膜を当該キャビティに突き合わせた状態で前記薬液容器を装填し、射出成形によって前記キャビティに熱可塑性樹脂を充填し、前記閉塞膜に樹脂製栓体を溶着する第2成形工程とを含み、第2成形工程時に前記樹脂製栓体の一部を容器内方側へ入り込ませ、前記薬液容器の閉塞膜を撓ませた状態で溶着させることを特徴とするものである。   The method for producing a stopper-equipped drug solution container according to the present invention comprises a first forming step for forming a thermoplastic resin drug solution container having a mouth for extracting a drug solution and having a closed film for closing the mouth, The drug solution container is loaded in a molding die provided with a cavity for molding a resin plug in a state where the closed film is abutted against the cavity, a thermoplastic resin is filled in the cavity by injection molding, and the closed film is filled. And a second forming step of welding the resin plug, wherein a part of the resin plug is inserted into the container in the second forming step, and welding is performed in a state where the closure film of the chemical solution container is bent. It is characterized in that

本発明の栓体付き薬液容器の製造方法では、薬液容器の口部の閉塞膜に、射出成形によって樹脂製栓体を溶着する際、樹脂製栓体の一部を容器内方側へ入り込ませ、薬液容器の閉塞膜を撓ませた状態で溶着させている。そのため、薬液容器の閉塞膜に樹脂製栓体が強固に溶着して一体化し、樹脂製栓体の密着性を格段に向上させることができる。これにより、多様な使用環境において液漏れを起こさないようにすることができる。   In the method of manufacturing a stoppered chemical liquid container according to the present invention, when welding a resin stopper by injection molding to the closing film of the opening of the liquid container, a part of the resin stopper is inserted into the container inner side. The welding is performed in a state where the closing film of the drug solution container is bent. Therefore, the resin plug is firmly welded and integrated to the closing film of the chemical solution container, and the adhesion of the resin plug can be significantly improved. Thereby, it is possible to prevent liquid leakage in various usage environments.

前記薬液容器は115〜150℃の加熱処理後における、可視光透過率の低下が5%以下である樹脂からなることが好ましい。このような樹脂として、直鎖状低密度ポリエチレンが挙げられる。直鎖状低密度ポリエチレンを用いることにより、熱滅菌処理後においても、高い透過性を維持することができる。   It is preferable that the said chemical | medical solution container consists of resin whose fall of the visible light transmittance | permeability is 5% or less after 115-150 degreeC heat processing. Linear low density polyethylene is mentioned as such resin. By using linear low density polyethylene, high permeability can be maintained even after heat sterilization.

前記薬液容器の口部に容器内方側へ窪ませた凹状部を形成し、前記樹脂製栓体の口部側部分を当該凹状部内で形成してもよい。この場合、樹脂製栓体の口部側部分を口部の凹状部内で締め込むような状態となり、薬液容器の閉塞膜と樹脂製栓体との密着性をさらに向上させることができる。 A recess may be formed in the mouth of the chemical solution container and may be recessed toward the inner side of the container, and the opening side portion of the resin plug may be formed in the recess. In this case, the mouth side portion of the resin plug body is tightened in the concave portion of the mouth portion, and the adhesion between the closure film of the drug solution container and the resin plug body can be further improved.

前記閉塞膜の厚みは200〜1100μmであることが好ましい。閉塞膜の厚みを200〜1100μmとすることで、薬液容器の閉塞膜が射出成形時の熱により軟化して撓み易くなり、当該閉塞膜に樹脂製栓体をより効果的に溶着させることができる。   The thickness of the occlusive membrane is preferably 200 to 1100 μm. By setting the thickness of the occlusive membrane to 200 to 1100 μm, the occlusive membrane of the drug solution container is softened and easily bent by the heat during injection molding, and the resin stopper can be more effectively welded to the occlusive membrane. .

前記薬液容器をブロー成形によって成形すれば、低コストかつ高品質の薬液容器を得ることができる。   By molding the chemical liquid container by blow molding, a low cost and high quality chemical liquid container can be obtained.

前記薬液容器をアンプル容器として構成し、複数のアンプル容器が互いに連結されるものとしてもよい。医療用途に用いることで、薬液の抽出時の周辺汚染を低減することができる。   The drug solution container may be configured as an ampoule container, and a plurality of ampoule containers may be connected to each other. By using for medical use, the surrounding contamination at the time of extraction of a medical fluid can be reduced.

本発明によれば、樹脂製栓体の一部を容器内方側へ入り込ませ、薬液容器の閉塞膜を撓ませた状態で溶着させているため、薬液容器の閉塞膜に樹脂製栓体が強固に溶着して一体化し、樹脂製栓体の密着性を格段に向上させることができる。これにより、液漏れを確実に防ぐことができる。   According to the present invention, the resin stopper is inserted into the closure film of the chemical liquid container because the resin stopper is inserted into the inner side of the container and welded while the closure film of the chemical container is bent. By firmly welding and integrating, it is possible to dramatically improve the adhesion of the resin plug. Thereby, liquid leakage can be reliably prevented.

本発明の一実施形態に係る栓体付き薬液容器の製造方法における、第1成形工程で成形した成形品の平面図と側面図である。It is the top view and side view of the molded article shape | molded at the 1st shaping | molding process in the manufacturing method of the chemical | medical solution container with stopper body which concerns on one Embodiment of this invention. 図1の成形品の口部側から見た正面図である。It is the front view seen from the opening | mouth part side of the molded article of FIG. 樹脂製栓体を設けた栓体付き薬液容器の正面図である。It is a front view of a stopper equipped drug solution container provided with a resin stopper. 第2成形工程を説明する説明図である。It is an explanatory view explaining a 2nd forming process. 第2成形工程を説明する説明図である。It is an explanatory view explaining a 2nd forming process. 栓体を設ける前の薬液容器と、栓体付き薬液容器の要部断面図である。It is principal part sectional drawing of a chemical | medical solution container before providing a stopper, and a chemical | medical solution container with a stopper. 他の形態における、栓体を設ける前の薬液容器と、栓体付き薬液容器の要部断面図である。It is a principal part sectional view of a medical fluid container before providing a stopper in other forms, and a medical fluid container with a stopper.

本発明の実施形態について説明する。図1は本発明の一実施形態に係る栓体付き薬液容器の製造方法における、第1成形工程で成形した成形品2の平面図と側面図である。図2は図1の成形品2の口部3側から見た正面図である。この成形品2は、複数のアンプル容器として形成された複数の薬液容器4と、これら複数の薬液容器4を連結している連結部分5とで構成されている。   Embodiments of the present invention will be described. FIG. 1 is a plan view and a side view of a molded article 2 molded in a first molding step in a method of manufacturing a stopper-equipped chemical liquid container according to an embodiment of the present invention. FIG. 2 is a front view of the molded article 2 of FIG. 1 as viewed from the mouth 3 side. The molded article 2 is composed of a plurality of drug solution containers 4 formed as a plurality of ampoule containers, and a connecting portion 5 connecting the plurality of drug solution containers 4.

薬液容器4は、円筒状の本体部6と、この本体部6の一端に形成されて薬液を抽出する口部3とで構成されている。本体部6は長手方向中央の胴部6aと、その両側の径大部6bで構成されている。連結部分5は複数の薬液容器4を互いに連結しており、複数の注入口5aを有している。薬液容器4の本体部6の他端は、注入口5aに連通しており、注入口5aから流し込んだ薬液が薬液容器4へ収容されるようになっている。薬液容器4に薬液を収容した後、薬液容器4側の他端の近傍で切断し、この切断部分をシールして薬液容器4を無菌状態で密閉する。   The drug solution container 4 includes a cylindrical main body 6 and an opening 3 formed at one end of the main body 6 for extracting the drug solution. The main body portion 6 is constituted by a trunk portion 6a at the center in the longitudinal direction and large diameter portions 6b on both sides thereof. The connection portion 5 connects a plurality of chemical solution containers 4 to one another, and has a plurality of injection ports 5a. The other end of the main body 6 of the drug solution container 4 is in communication with the injection port 5a, and the drug solution poured from the injection port 5a is accommodated in the drug solution container 4. After the drug solution is stored in the drug solution container 4, it is cut in the vicinity of the other end on the drug solution container 4 side, and the cut portion is sealed to seal the drug solution container 4 in a sterile state.

図2のように薬液容器4の口部3には、この口部3を閉塞する閉塞膜10が形成されている。薬液容器4の肉厚は100〜500μmであり、閉塞膜10の厚みは200〜1100μmが好ましい。図3は樹脂製栓体11を設けた栓体付き薬液容器1の正面図である。同図に示すように栓体付き薬液容器1は、薬液容器4とこの薬液容器4の口部3に設けられた樹脂製栓体11とで構成されている。略円柱状の樹脂製栓体11は、薬液容器4の口部3を塞ぐようにして閉塞膜10に溶着されている。   As shown in FIG. 2, the opening 3 of the drug solution container 4 is formed with a closing film 10 for closing the opening 3. The thickness of the drug solution container 4 is 100 to 500 μm, and the thickness of the occlusive film 10 is preferably 200 to 1100 μm. FIG. 3 is a front view of the stoppered drug solution container 1 provided with the resin stopper 11. As shown in the figure, a stoppered chemical solution container 1 is constituted of a chemical solution container 4 and a resin stopper 11 provided at the mouth 3 of the chemical solution container 4. The substantially cylindrical resin plug 11 is welded to the blocking film 10 so as to close the opening 3 of the drug solution container 4.

栓体付き薬液容器1を製造する方法を説明する。栓体付き薬液容器1は、第1成形工程であるブロー成形によって薬液容器4を成形し、次の第2成形工程である射出成形によって薬液容器4の口部3に樹脂製栓体11を溶着することによって製造する。薬液容器4を成形する第1成形工程で用いるブロー成形は公知の方法を用いることができる。具体的には、金型内に連続的に押し出された溶融樹脂製のパリソンを挟みエアを吹き込むダイレクトブロー成形、又は射出成形などによって成形したプリフォームにストレッジロッドを進入させながらエアを吹き込む二軸延伸ブロー成形などが挙げられる。薬液容器4をブロー成形によって成形すれば、低コストかつ高品質の薬液容器4を得ることができる。   A method of manufacturing the stoppered chemical solution container 1 will be described. The stoppered chemical solution container 1 forms the chemical solution container 4 by blow molding, which is a first forming step, and welds the resin stopper 11 to the opening 3 of the chemical solution container 4 by injection molding, which is the next second forming step. Manufacture by doing. The blow molding used in the first molding step for molding the drug solution container 4 can use a known method. More specifically, the air is blown into a preform molded by direct blow molding in which air is blown by sandwiching a parison made of molten resin continuously extruded in a mold, or by injection molding while the storage rod is advanced. Stretch blow molding and the like can be mentioned. By molding the drug solution container 4 by blow molding, it is possible to obtain the drug solution container 4 with low cost and high quality.

ブロー成形で薬液容器4を成形した後、次の第2成形工程の射出成形によって薬液容器4の口部3を塞ぐように樹脂製栓体11を溶着する。図4及び図5はそれぞれ第2成形工程を説明する説明図である。射出成形金型(成形金型)12は2つ割の金型からなり、図示の一方の金型13と図示しない他方の金型によって樹脂製栓体11を成形するキャビティ14が構成されている。図4は薬液容器4を射出成形金型12に装填する前の状態を示し、図5は装填後の状態を示している。   After the drug solution container 4 is formed by blow molding, the resin plug 11 is welded so as to close the opening 3 of the drug solution container 4 by injection molding in the next second forming process. FIG.4 and FIG.5 is explanatory drawing explaining a 2nd shaping | molding process, respectively. The injection molding die (molding die) 12 is composed of two halves, and a cavity 14 for molding the resin plug body 11 is constituted by one die 13 shown in the drawing and the other die not shown. . FIG. 4 shows the state before the chemical solution container 4 is loaded into the injection mold 12, and FIG. 5 shows the state after loading.

金型13には、キャビティ14に連通するように、薬液容器4の口部3の形に構成された装填型部15が設けられている。図5のように薬液容器4の口部3を金型13の装填型部15に合わせ、口部3の閉塞膜10をキャビティ14に突き合わせた状態で薬液容器4を装填する。その後、射出成形金型12を型閉し、キャビティ14に溶融した熱可塑性樹脂を充填する。キャビティ14に溶融した熱可塑性樹脂を充填することによって、樹脂製栓体11を成形するのと同時に、閉塞膜10に樹脂製栓体11を溶着する。   The mold 13 is provided with a loading mold 15 configured in the form of the opening 3 of the chemical solution container 4 so as to communicate with the cavity 14. As shown in FIG. 5, the mouth 3 of the medicine container 4 is aligned with the loading mold 15 of the mold 13, and the medicine container 4 is loaded with the closed film 10 of the mouth 3 butted against the cavity 14. Thereafter, the injection mold 12 is closed, and the cavity 14 is filled with the molten thermoplastic resin. By filling the cavity 14 with the melted thermoplastic resin, the resin plug 11 is welded to the blocking film 10 at the same time as the resin plug 11 is formed.

図6は樹脂製栓体11を設ける前の薬液容器4と、栓体付き薬液容器1の要部断面図である。第2成形工程である射出成形時に樹脂製栓体11の一部11aを容器内方側へ入り込ませ、同図のように薬液容器4の閉塞膜10を容器内方側へ撓ませた状態で溶着させている。溶融した熱可塑性樹脂がキャビティ14に充填されるのと同時に、薬液容器4の閉塞膜10が押圧されて硬化することで、樹脂製栓体11の一部11aが、口部3の外端3aよりも容器内方側へ若干入り込み、薬液容器4の閉塞膜10が容器内方側へ撓んだ状態となる。樹脂製栓体11の一部11aの容器内方側への入り込み寸法である閉塞膜10の最大撓み寸法は100〜2000μm程度である。   FIG. 6 is a cross-sectional view of main parts of the drug solution container 4 and the drug solution container 1 with a plug before the resin plug 11 is provided. In a state in which the part 11a of the resin plug 11 is inserted into the container inward at the time of injection molding which is the second molding step, and the closure film 10 of the drug solution container 4 is bent inward as shown in FIG. It is welded. At the same time as the melted thermoplastic resin is filled in the cavity 14, the closing film 10 of the drug solution container 4 is pressed and hardened so that the part 11 a of the resin plug 11 is the outer end 3 a of the opening 3 Rather, it slightly enters the inner side of the container, and the closure film 10 of the drug solution container 4 is bent to the inner side of the container. The maximum deflection dimension of the occlusive membrane 10, which is the penetration dimension of the part 11a of the resin plug 11 into the container inner side, is about 100 to 2000 μm.

即ち、次の栓体付き薬液容器の製造方法を実施する。薬液を抽出する口部3を有すると共にこの口部3を閉塞する閉塞膜10が形成された熱可塑性樹脂製の薬液容器4を形成する第1成形工程と、樹脂製栓体11を成形するキャビティ14を備える射出成形金型12に、閉塞膜10をキャビティ14に突き合わせた状態で、薬液容器4を装填し、射出成形によってキャビティ14に熱可塑性樹脂を充填し、閉塞膜10に樹脂製栓体11を溶着する第2成形工程とを含み、第2成形工程時に樹脂製栓体11の一部11aを容器内方側へ入り込ませ、薬液容器4の閉塞膜10を撓ませた状態で溶着させる栓体付き薬液容器の製造方法である。   That is, the following method for manufacturing a stoppered chemical container is carried out. A first forming step of forming a liquid medicine container 4 made of thermoplastic resin having a mouth 3 for extracting a medicine and a closure film 10 for closing the mouth 3 and a cavity for molding a resin stopper 11 The medical fluid container 4 is loaded in a state in which the closed film 10 is in contact with the cavity 14 in the injection molding die 12 having the injection mold 14, and the cavity 14 is filled with a thermoplastic resin by injection molding. 11 includes a second forming step of welding 11, and in the second forming step, a part 11a of the resin stopper 11 is introduced into the container inward side, and the closure film 10 of the drug solution container 4 is welded in a bent state It is a manufacturing method of a medical fluid container with a stopper.

樹脂製栓体11の一部11aを容器内方側へ入り込ませるのは、キャビティ14に溶融した熱可塑性樹脂を充填することによる閉塞膜10への押圧力による作用、又は、閉塞膜10への当該押圧力と、閉塞膜10の伸縮の双方の作用、によるものである。閉塞膜10の伸張は、射出成形時の熱の影響による閉塞膜10自体の膨張及び口部3の径外方向への拡張によるものであり、閉塞膜10の収縮は、射出成形の離型時の温度変化の影響による閉塞膜10自体の収縮及び口部3の径内方向への収縮によるものである。   The part 11 a of the resin plug 11 can be introduced into the inside of the container because the cavity 14 is filled with the molten thermoplastic resin and the pressure on the occlusive membrane 10 is exerted or the occlusive membrane 10 is It is due to the action of both the pressing force and the expansion and contraction of the occlusive membrane 10. The expansion of the occlusive membrane 10 is due to the expansion of the occlusive membrane 10 itself due to the influence of heat at the time of injection molding and the radial outward expansion of the opening 3, and the contraction of the occlusive membrane 10 at the time of mold release of injection molding. The contraction of the occlusive membrane 10 itself and the contraction of the mouth 3 in the radial direction due to the influence of the temperature change.

樹脂製栓体11の一部11aが僅かでも口部3の外端3aよりも容器内方側へ入り込み、薬液容器4の閉塞膜10が撓んだ状態となっていればよい。閉塞膜10が、容器内方側へ入り込んだ樹脂製栓体11の一部11aを掴むような状態となる。このような状態で樹脂製栓体11が薬液容器4の閉塞膜10に溶着していることで、閉塞膜10に樹脂製栓体11が強固に溶着して完全に一体化し、樹脂製栓体11の密着性を格段に向上させることができる。   It is sufficient that the part 11a of the resin-made plug body 11 enters the container inward side more than the outer end 3a of the opening 3 and the closure film 10 of the drug solution container 4 is in a bent state. The occlusive membrane 10 is in a state of gripping the part 11 a of the resin plug 11 that has entered the inside of the container. Since the resin plug 11 is welded to the closure film 10 of the drug solution container 4 in such a state, the resin plug 11 is firmly welded to the closure film 10 and completely integrated, and the resin plug The adhesion of 11 can be significantly improved.

閉塞膜10の厚みは200〜1100μmとしており、閉塞膜10が200μmよりも小さいと強度を維持し難くなり、1100μmを超えると閉塞膜10が熱により軟化し難くなり、溶着力が低下する。閉塞膜10の厚みを200〜1100μmとすることで、射出成形時の熱により軟化して撓み易くなり、樹脂製栓体11をより効果的に溶着させることができる。   When the thickness of the occlusive film 10 is smaller than 200 μm, it becomes difficult to maintain the strength. When the thickness of the occlusive film 10 exceeds 1100 μm, the occlusive film 10 becomes difficult to soften by heat, and the welding strength decreases. By setting the thickness of the occlusive film 10 to 200 to 1100 μm, the film can be softened and easily bent by heat during injection molding, and the resin plug 11 can be welded more effectively.

樹脂製栓体11を構成する材料は限定されず、具体的には熱可塑性樹脂であるポリプロピレン、ポリエチレンなどのポリオレフィン、ポリエチレンナフタレート、ポリエチレンテレフタレートなどのポリエステル、ナイロン6などのポリアミド、ABS樹脂、などが挙げられる。樹脂製栓体11を構成する最も好適な材料としては、熱可塑性樹脂弾性体であるスチレン系エラストマー、オレフィン系エラストマー、ウレタン系エラストマー、ポリエステル系エラストマー、ニトリル系エラストマー、ポリアミド系エラストマー、フッ素系エラストマー、塩化ビニル系エラストマー、シリコン系エラストマー、イソブテンとイソプレンの重合体(ポリイソブチレン)が挙げられ、これら1種類であってもよいし、2種以上を混合して使用してもよい。   The material constituting the resin stopper 11 is not limited, and specifically, thermoplastic resin such as polypropylene, polyolefin such as polyethylene, polyethylene naphthalate, polyester such as polyethylene terephthalate, polyamide such as nylon 6, ABS resin, etc. Can be mentioned. The most preferable materials for forming the resin-made plug body 11 include styrene-based elastomers that are thermoplastic resin elastic bodies, olefin-based elastomers, urethane-based elastomers, polyester-based elastomers, nitrile-based elastomers, polyamide-based elastomers, fluorine-based elastomers, There may be mentioned vinyl chloride-based elastomers, silicone-based elastomers, polymers of isobutene and isoprene (polyisobutylene), and these may be used alone or in combination of two or more.

その中でもスチレン系エラストマーが好ましい。スチレン系エラストマーには、SBS系(スチレン・ブタジエン・スチレン)、SIS系(スチレン・イソプレン・スチレン)、SEBS系(スチレン・エチレン・ブチレン・スチレン)、SEPS系(スチレン・エチレン・プロピレン・スチレン)が代表的であり、これら1種類であってもよいし、これらに各種の添加物を添加したコンパウンド材料でもよい。   Among them, styrenic elastomers are preferred. Styrene-based elastomers include SBS-based (styrene-butadiene-styrene), SIS-based (styrene-isoprene-styrene), SEBS-based (styrene-ethylene-butylene-styrene), and SEPS-based (styrene-ethylene-propylene-styrene). It is representative, and may be one kind of these, or it may be a compound material which added various additives to these.

薬液容器4を構成する材料は限定されず、具体的には熱可塑性樹脂であるポリプロピレン、ポリエチレンなどのポリオレフィン、ポリエチレンナフタレート、ポリエチレンテレフタレートなどのポリエステル、ナイロン6などのポリアミド、ABS樹脂、などが挙げられる。その中でも最も好適な材料として直鎖状低密度ポリエチレンが挙げられる。直鎖状低密度ポリエチレンの具体例として、特開2015−74917号公報、特開2015−96190号公報などの公知文献に開示されている材料が挙げられる。薬液容器4に、同公報で開示された直鎖状低密度ポリエチレンを使用することで、115〜150℃の加熱処理後における、可視光(波長380nm〜780nm)透過率の低下を5%以下に抑えることができる。特に、上記の直鎖状低密度ポリエチレンを用いることで、例えば450nmの光に対する55%以上の透過率を維持することが可能となり、日本薬局方に適合させることができる。   The material constituting the chemical solution container 4 is not particularly limited, and specifically, thermoplastic resin such as polypropylene, polyolefin such as polyethylene, polyethylene naphthalate, polyester such as polyethylene terephthalate, polyamide such as nylon 6, ABS resin, etc. Be Among them, linear low density polyethylene is mentioned as the most suitable material. As a specific example of linear low density polyethylene, materials disclosed in publicly known documents such as JP-A-2015-74917 and JP-A-2015-96190 can be mentioned. By using the linear low density polyethylene disclosed in the same publication for the chemical solution container 4, the reduction of the visible light (wavelength 380 nm to 780 nm) transmittance after the heat treatment at 115 to 150 ° C. is 5% or less It can be suppressed. In particular, by using the above-mentioned linear low density polyethylene, it is possible to maintain, for example, a transmittance of 55% or more for light of 450 nm, and it is possible to conform to the Japanese Pharmacopoeia.

薬液容器4には加熱による滅菌処理(加熱処理)が施される。薬液容器4を加熱することにより、構成している樹脂の結晶化度が上昇し、透明性が低下する。上記の直鎖状低密度ポリエチレンを使用した場合、熱が加えられてもその分子構造上、結晶化の上昇が抑えられ、透明性の高い薬液容器4を得ることができる。薬液容器4に、同公報で開示された直鎖状低密度ポリエチレンを使用することで、滅菌処理後の形状変化も抑えることができる。   The medical fluid container 4 is subjected to a sterilization process (heat process) by heating. By heating the chemical solution container 4, the degree of crystallization of the constituent resin is increased, and the transparency is reduced. When the above linear low density polyethylene is used, an increase in crystallization can be suppressed due to its molecular structure even if heat is applied, and the highly transparent drug solution container 4 can be obtained. By using the linear low density polyethylene disclosed in the same publication for the drug solution container 4, it is possible to suppress the shape change after sterilization.

薬液容器4に上記の直鎖状低密度ポリエチレンを用いるさらなる利点として、内容物である薬液を絞り出す操作を行った場合のスクイズ性の向上が挙げられる。これにより、排液性の高い薬液容器4とすることができる。   As a further advantage of using the above-mentioned linear low density polyethylene for the drug solution container 4, the improvement of the squeeze property in the operation of squeezing out the drug solution which is the contents is mentioned. Thereby, it can be set as the medical fluid container 4 with high drainage nature.

薬液容器4としてのアンプル容器を3つ製作し、滅菌処理前のアンプル容器A及びBと、121℃、15分で滅菌処理した後のアンプル容器Cの可視光透過率を測定した。各試料で異なる3カ所の部分の厚みと、可視光である波長450nmの光に対する透過率を測定した。厚みの単位はμm、可視光透過率の単位は%である。滅菌処理前のアンプル容器Aの厚みは320、280、300、各々の可視光透過率は63.1、71.7、69.2であった。滅菌処理前のアンプル容器Bの厚みは330、290、330、各々の可視光透過率は62.3、68.7、62.9であった。   Three ampoule containers as the drug solution container 4 were manufactured, and the visible light transmittances of the ampoule containers A and B before sterilization treatment and the ampoule container C after sterilization treatment at 121 ° C. for 15 minutes were measured. The thickness of three different portions of each sample and the transmittance for visible light having a wavelength of 450 nm were measured. The unit of thickness is μm, and the unit of visible light transmittance is%. The thickness of the ampoule container A before sterilization treatment was 320, 280, 300, and the visible light transmittance of each was 63.1, 71.7, 69.2. The thickness of ampoule container B before sterilization treatment was 330, 290, 330, and the visible light transmittance of each was 62.3, 68.7, 62.9.

滅菌処理後のアンプル容器Cの厚みは340、390、320、各々の可視光透過率は57.1、53.5、58.6であった。滅菌処理後のアンプル容器Cの可視光透過率は53.5〜58.6%を示した。例えば厚みの320μmの部分では、滅菌処理前のアンプル容器Aの可視光透過率は63.1であり、滅菌処理後のアンプル容器Cの可視光透過率は58.6%であり、可視光透過率が4.5%低下に抑えられた。   The thickness of ampoule container C after sterilization treatment was 340, 390, 320, and the visible light transmittance of each was 57.1, 53.5, 58.6. The visible light transmittance of the ampoule container C after sterilization was 53.5 to 58.6%. For example, in the 320 μm thick portion, the visible light transmittance of the ampoule container A before sterilization is 63.1, and the visible light transmittance of the ampoule container C after sterilization is 58.6%, and the visible light transmission is The rate was reduced to 4.5%.

本実施形態の栓体付き薬液容器の製造方法では、薬液容器4の口部3の閉塞膜10に、射出成形によって樹脂製栓体11を溶着する際、樹脂製栓体11の一部11aを容器内方側へ入り込ませ、薬液容器4の閉塞膜10を撓ませた状態で溶着させている。そのため、閉塞膜10に樹脂製栓体11が強固に溶着して一体化し、空気層が存在せず、樹脂製栓体11の密着性を格段に向上させることができる。これにより、多様な使用環境において液漏れを確実に防ぐことができる。   In the method of manufacturing the stopper-equipped drug solution container of the present embodiment, the part 11 a of the resin-made plug member 11 is welded to the closure film 10 of the opening 3 of the drug solution container 4 by injection molding. It is made to enter inside the container, and welding is performed in a state where the closure film 10 of the drug solution container 4 is bent. Therefore, the resin plug 11 is firmly welded and integrated to the occlusive film 10, and an air layer does not exist, and the adhesion of the resin plug 11 can be remarkably improved. As a result, liquid leakage can be reliably prevented in various usage environments.

例えば医療現場において、注射器の針を樹脂製栓体11に刺し、閉塞膜10を貫通させて薬液を抽出する際、閉塞膜10に樹脂製栓体11が強固に溶着しているため、薬液が漏れることがなく周辺汚染を低減することができる。そのため、クリーンブース外での無菌操作が可能となり、医療現場における作業性が向上する。   For example, at the medical site, when the needle of the syringe is pierced through the resin plug 11 and the occlusive membrane 10 is penetrated to extract the drug solution, the resin plug 11 is firmly welded to the occlusive membrane 10, so It is possible to reduce surrounding pollution without leaking. Therefore, aseptic operation outside the clean booth becomes possible, and the workability at the medical site is improved.

本実施形態の成形品2では、複数の薬液容器4が互いに連結されており、複数の栓体付き薬液容器1を製造した後、薬液が各栓体付き薬液容器1に収容される。その後、結合導入部5が切り取られると共に、切り取り部分がシールされ、複数のアンプルが連結された製品となる。薬液が収容された薬液製品の製造方法として、ブローフィルシールが公知である。この製造方法を用いる場合、熱が加わるのを嫌うタンパク製剤を収容することはできない。本実施形態の栓体付き薬液容器1では、薬液を収容した後は熱が加えられないため、タンパク製剤などの熱が加わるのを嫌う薬液を収容する場合に好適である。   In the molded article 2 of the present embodiment, a plurality of chemical solution containers 4 are connected to each other, and after manufacturing the plurality of stopper-equipped chemical solution containers 1, the chemical solution is accommodated in each stopper-equipped chemical solution container 1. Thereafter, the bonding introduction portion 5 is cut off, and the cut portion is sealed to provide a product in which a plurality of ampoules are connected. A blow fill seal is known as a method for producing a drug product containing a drug solution. When using this method of production, it is not possible to accommodate protein preparations that are disgusting to heat. In the stopper-equipped drug solution container 1 of the present embodiment, heat is not applied after the drug solution is stored, and therefore, it is suitable for storing a drug solution that does not like heat, such as a protein preparation.

図7は他の形態における、樹脂製栓体21を設ける前の薬液容器22と、栓体付き薬液容器20の要部断面図である。薬液容器22の口部23に容器内方側へ窪ませた凹状部23aが形成されている。樹脂製栓体21の口部側部分21aがこの凹状部23a内で形成されている。射出成形時の温度で軟化した状態の薬液容器22の口部23の凹状部23a内で、樹脂製栓体21の口部側部分21aが形成され、その後、当該凹状部23aが冷却されて収縮する。この作用によって、樹脂製栓体21の口部側部分21aが凹状部23a内でかしめられた状態となっている。   FIG. 7 is a cross-sectional view of main parts of the drug solution container 22 and the drug solution container 20 with a plug, before providing the resin plug 21 in another embodiment. A recessed portion 23 a is formed in the mouth 23 of the chemical solution container 22 so as to be recessed toward the inside of the container. The mouth side portion 21a of the resin plug 21 is formed in the concave portion 23a. The opening-side portion 21a of the resin plug 21 is formed in the recess 23a of the opening 23 of the drug solution container 22 in a state of being softened at the temperature during injection molding, and then the recess 23a is cooled and contracted. Do. By this action, the mouth side portion 21a of the resin plug 21 is crimped in the concave portion 23a.

上記実施形態と同様に、樹脂製栓体21の一部21bが容器内方側へ入り込んでおり、薬液容器22の閉塞膜24を撓ませた状態で溶着させている。閉塞膜24が、容器内方側へ入り込んだ、樹脂製栓体21の一部21bを掴むような状態となる。このような状態で樹脂製栓体21が薬液容器22の閉塞膜24に溶着していることで、閉塞膜24に樹脂製栓体21が強固に溶着して完全に一体化し、樹脂製栓体21の密着性を格段に向上させることができる。   As in the above embodiment, the part 21 b of the resin plug 21 is inward of the container, and welding is performed in a state in which the blocking film 24 of the drug solution container 22 is bent. The occlusive membrane 24 is in a state of gripping the part 21b of the resin plug 21 which has entered the inside of the container. Since the resin plug 21 is welded to the closure film 24 of the drug solution container 22 in such a state, the resin plug 21 is firmly welded to the closure film 24 and completely integrated, and the resin plug The adhesion of 21 can be significantly improved.

さらに樹脂製栓体21の口部側部分21aが口部23でかしめられているため、樹脂製栓体21の口部側部分21aが口部23で締め込まれる状態となる。それに加え、樹脂製栓体21と口部23との接触面積が増加する。これらにより、薬液容器22の閉塞膜24と樹脂製栓体21との密着性をさらに向上させることができる。   Furthermore, since the mouth side portion 21 a of the resin plug 21 is crimped by the mouth 23, the mouth side portion 21 a of the resin stopper 21 is tightened with the mouth 23. In addition, the contact area between the resin plug 21 and the opening 23 is increased. Thus, the adhesion between the blocking film 24 of the drug solution container 22 and the resin plug 21 can be further improved.

本実施形態の栓体付き薬液容器の製造方法は、本発明に係る栓体付き薬液容器の製造方法を例示したものである。薬液容器及び樹脂製栓体の形状及び寸法は限定されない。本発明の栓体付き薬液容器の製造方法に、必要に応じて他の工程を含めるようにしてもよい。本発明の栓体付き薬液容器の製造方法で製造する栓体付き薬液容器は、アンプル容器に限られず、薬液を収容するものであればよい。   The method for producing a stopper-equipped drug solution container of the present embodiment exemplifies the method for producing a stopper-equipped drug solution container according to the present invention. The shape and dimensions of the drug solution container and the resin stopper are not limited. Other steps may be included in the method for producing a stopper-equipped drug solution container of the present invention as required. The stopper-equipped drug solution container manufactured by the method for manufacturing a plug-equipped drug solution container of the present invention is not limited to an ampoule container, and any container may be used as long as it can store a drug solution.

1、20 栓体付き薬液容器
2 成形品
3、23 口部
4、22 薬液容器
10、24 閉塞膜
11、21 樹脂製栓体
11a、21b 樹脂製栓体の一部
21a 樹脂製栓体の口部側部分
23a 凹状部
12 射出成形金型
13 金型
14 キャビティ
15 装填型部
1, 20 stoppered chemical liquid container 2 molded article 3, 23 mouth 4, 22 chemical liquid container 10, 24 closed film 11, 21 resin plug 11a, 21b part of resin plug 21a of resin plug Part side part 23a concave part 12 injection molding die 13 die 14 cavity 15 loaded die part

Claims (7)

薬液を抽出する口部を有すると共にこの口部を閉塞する閉塞膜が形成された熱可塑性樹脂製の薬液容器を形成する第1成形工程と、
樹脂製栓体を成形するキャビティを備える成形金型に、前記閉塞膜を当該キャビティに突き合わせた状態で前記薬液容器を装填し、射出成形によって前記キャビティに熱可塑性樹脂を充填し、前記閉塞膜に樹脂製栓体を溶着する第2成形工程と、を含み、
第2成形工程時に前記樹脂製栓体の一部を容器内方側へ入り込ませ、前記薬液容器の閉塞膜を撓ませた状態で溶着させることを特徴とする栓体付き薬液容器の製造方法。
A first forming step of forming a thermoplastic resin drug solution container having a mouth for extracting a drug solution and a closed film for closing the mouth formed thereon;
The drug solution container is loaded in a molding die provided with a cavity for molding a resin plug in a state where the closed film is abutted against the cavity, a thermoplastic resin is filled in the cavity by injection molding, and the closed film is filled. A second forming step of welding the resin plug body;
A method of manufacturing a stopper-equipped drug solution container, wherein a part of the resin plug is inserted into the container in the second forming step, and welding is performed in a state where the closure film of the drug solution container is bent.
前記薬液容器は115〜150℃の加熱処理後における、可視光透過率の低下が5%以下である樹脂からなることを特徴とする請求項1に記載の栓体付き薬液容器の製造方法。   The method according to claim 1, wherein the chemical solution container is made of a resin having a visible light transmittance of 5% or less after the heat treatment at 115 to 150 ° C. 前記薬液容器は直鎖状低密度ポリエチレンからなることを特徴とする請求項2に記載の栓体付き薬液容器の製造方法。   The method for manufacturing a stoppered chemical container according to claim 2, wherein the chemical container is made of linear low density polyethylene. 前記薬液容器の口部に容器内方側へ窪ませた凹状部が形成されており、前記樹脂製栓体の口部側部分当該凹状部内で形成することを特徴とする請求項1〜3のいずれかに記載の栓体付き薬液容器の製造方法。 The concave portion recessed toward the inner side of the container is formed at the mouth of the chemical solution container, and the mouth side portion of the resin plug is formed in the concave portion. The manufacturing method of the chemical | medical solution container with stopper body in any one of-. 前記閉塞膜の厚みは200〜1100μmであることを特徴とする請求項1〜4のいずれかに記載の栓体付き薬液容器の製造方法。   The thickness of the said occlusion film is 200-1100 micrometers, The manufacturing method of the chemical | medical solution container with a stopper as described in any one of the Claims 1-4 characterized by the above-mentioned. 前記薬液容器はブロー成形によって成形されていることを特徴とする請求項1〜5のいずれかに記載の栓体付き薬液容器の製造方法。   The method for manufacturing a stopper-equipped liquid drug container according to any one of claims 1 to 5, wherein the liquid drug container is formed by blow molding. 前記薬液容器はアンプル容器であり、複数のアンプル容器が互いに連結されていることを特徴とする請求項1〜6のいずれかに記載の栓体付き薬液容器の製造方法。   The method according to any one of claims 1 to 6, wherein the drug solution container is an ampoule container, and a plurality of ampoule containers are connected to each other.
JP2015165849A 2015-08-25 2015-08-25 Method of manufacturing chemical container with stopper Active JP6521449B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2015165849A JP6521449B2 (en) 2015-08-25 2015-08-25 Method of manufacturing chemical container with stopper

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2015165849A JP6521449B2 (en) 2015-08-25 2015-08-25 Method of manufacturing chemical container with stopper

Publications (2)

Publication Number Publication Date
JP2017042964A JP2017042964A (en) 2017-03-02
JP6521449B2 true JP6521449B2 (en) 2019-05-29

Family

ID=58209295

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2015165849A Active JP6521449B2 (en) 2015-08-25 2015-08-25 Method of manufacturing chemical container with stopper

Country Status (1)

Country Link
JP (1) JP6521449B2 (en)

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0214119A (en) * 1989-05-10 1990-01-18 Aoki Shigeto Secondary injection molding method for thin wall hollow molded product
JP2931996B2 (en) * 1990-07-26 1999-08-09 三菱樹脂株式会社 Manufacturing method of plastic bottle with handle
JPH0613708Y2 (en) * 1991-04-05 1994-04-13 株式会社ニッショー Infusion container
JP2558057B2 (en) * 1993-11-18 1996-11-27 扶桑薬品工業株式会社 Closure method of synthetic resin container mouth for infusion
JP2000189492A (en) * 1998-10-21 2000-07-11 Nissho Corp Albumin preparation storage container and its manufacture
JP2001314485A (en) * 2000-05-11 2001-11-13 Naigai Kasei Kk Medical plug body and medical cap
DK1616549T3 (en) * 2003-04-23 2012-11-05 Otsuka Pharma Co Ltd PLASTIC PUMP FOR A MEDICINAL SOLUTION FILL AND PROCEDURE FOR PREPARING THEREOF
JP6295588B2 (en) * 2013-10-10 2018-03-20 東ソー株式会社 Polyethylene resin composition and medical container comprising the same

Also Published As

Publication number Publication date
JP2017042964A (en) 2017-03-02

Similar Documents

Publication Publication Date Title
CN101370546B (en) Pre-filled hypodermic syringe fitted with a stoppering device
US10278896B2 (en) Ampoule for a medical liquid, and method for producing an ampoule
JP2000140068A (en) Needle piercing detent plug, and its manufacture
US10639839B2 (en) Aseptic containment device and process for its production and assembly
JP6235561B2 (en) Syringe with injection needle and method for producing syringe with injection needle
KR101817492B1 (en) Multi-chamber vessel
KR101532257B1 (en) Double-chamber container
JP2024023478A (en) Primary packaging for pharmaceutical substances
JP4477216B2 (en) Cap, method of manufacturing the same, and drug container using the cap
JP6521449B2 (en) Method of manufacturing chemical container with stopper
JPH03205141A (en) Manufacture of medical plastic container stopper
JP2001245958A (en) Lid member for medical fluid container, and manufacturing method therefor
JP2016007248A (en) Medical container
JP5594687B2 (en) Drug discharge tool and multi-chamber container using drug discharge tool
JP5605181B2 (en) Manufacturing method of plastic ampule for chemical liquid and plastic ampule for chemical liquid
JP2010075392A (en) Medical cap and method for manufacturing the same
JP3517919B2 (en) Medical containers and molding dies
CN103156772A (en) Transfusion container and manufacturing method thereof
JP2018012025A (en) Syringe with injection needle and manufacturing method of syringe with injection needle
JP4797718B2 (en) Plug with integrated dissimilar materials
JP7016519B2 (en) Medical cap and its manufacturing method
JP2004187948A (en) Method of manufacturing medical container, and medical container
JP7011802B2 (en) Medical cap and its manufacturing method
JPH10328270A (en) Freeze drying container and manufacture of medical container using it
JPH04117636U (en) Infusion container

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20180517

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20190327

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20190329

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20190408

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20190417

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20190419

R150 Certificate of patent or registration of utility model

Ref document number: 6521449

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250